Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Cell & Gene Therapy Asia 2019

Takahiro Ochiya's Biography

Takahiro Ochiya, Professor, Tokyo Medical University

Dr. Takahiro Ochiya was a Chief of Division of Molecular and Cellular Medicine at the National Cancer Center Research Institute, Tokyo since 2011 and he is currently appointed as Professor at Tokyo Medical University (since 2018). After he got Ph.D. in 1988 in Osaka University and then went to do a post-doc at La Jolla Cancer Research (Burnham Institute for Medical Research), CA, USA. Dr. Ochiya’s lab focuses the development of novel animal models, methods, and strategies to study cancer development and metastasis. Especially, current focus areas are siRNA- and microRNA-based therapy against cancer stem cells and Exosome research in cancer area. He carries the role of President of Japanese Society of Extracellular Vesicles (JSEV) since 2014.

Takahiro Ochiya Image

Exosome-based Cell Free Therapy

Monday, 11 November 2019 at 12:00

Add to Calendar ▼2019-11-11 12:00:002019-11-11 13:00:00Europe/LondonExosome-based Cell Free TherapyCell and Gene Therapy Asia 2019 in Kobe, JapanKobe,

Extracellular vesicles (EVs) play important roles in intercellular communications via their content molecules, and mimic, at least in part, the roles that are played by their originating cells. Consistent with this notion, an increasing number of reports have suggested that EVs including exosomes derived from mesenchymal stem cells (MSCs), which are therapeutically beneficial to a wide range of diseases, can serve as drugs to treat multiple diseases. EVs contain a variety of molecules, including proteins, microRNAs, and mRNAs, and are associated with biological processes in a content molecule-dependent manner. In this presentation, it will be reviewed the latest reports regarding the therapeutic potential of MSC-EVs by focusing on the underlying molecular mechanisms of their effects. Specifically, it will be notified the effects of MSC-EVs in terms of their content molecules and of the tissue recovery processes endowed by these molecules for exosome-based cell-free therapy.

Add to Calendar ▼2019-11-11 00:00:002019-11-12 00:00:00Europe/LondonCell and Gene Therapy Asia 2019Cell and Gene Therapy Asia 2019 in Kobe, JapanKobe,